Assessing the current dealmaking environment for psychedelic medicine.
Joseph Haas and Emma Wille overview the dealmaking environment for psychedelic medicine given recent developments in the space: Eli Lilly's...
Radio and PodcastLive Radio & Podcasts
Business
Pharma Intelligence Podcasts
Pharma Intelligence from Informa places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfe...
Episodes
20 of 615 episodes
Digital Health Roundup: Oura Plans IPO, FDA’s Home Health, Digital Tools For Alzheimer’s Detection
In this month: Marion Webb highlights Oura’s IPO, new partnerships, and a class-action lawsuit. George Underwood discusses digital tools for...
Strategic Intent: Next‑Generation Cancer Vaccines And Nouscom’s Strategy For Interception And Personalization
"Personalized and off‑the‑shelf cancer vaccines are moving from concept to clinic, raising new questions about differentiation, manufacturab...
Scaling Self-Care In Asia Pacific, With APSMI's Rachmadi Joesoef and Anama O'Reilly
In this episode of Over the Counter, now also in video, HBW Insight talks to Rachmadi Joesoef, APSMI chair and CEO of Indonesian manufacture...
Drug Fix: Increasing US FDA Leadership Stability And Where All The Adcomms Have Gone
Pink Sheet Executive Editor Derrick Gingery, Senior Editor Sue Sutter, Editor-in-Chief Nielsen Hobbs and Prevision Policy Founding Member Mi...
Strategic Intent: Evolving Requirements Of Life Sciences Leadership
In this episode of Strategic Intent, Nick Stephens, chairman of the recruitment and executive placement company RSA group, looks at the stat...
Drug Fix: US FDA Commissioner Nominee Heidi Overton’s Resume And COVID-19 Vaccine Trial Changes
Pink Sheet Executive Editor Derrick Gingery, Senior Editor Sue Sutter, Senior Reporter Maaisha Osman, and Editor-in-Chief Nielsen Hobbs disc...
Proof Of Concept: How A Charity Bridges Lab And Clinic
Cancer Research UK is best known for funding science. But its commercial arm, Cancer Research Horizons, does something less obvious: it buil...
Off-Patent, On Record: A Story Of Patients Fighting For Accessible Cystic Fibrosis Treatment
In the second episode of Off-Patent, On Record, Generics Bulletin’s senior reporter Urtė Fultinavičiūtė hears how patients with cystic fibro...
Strategic Intent: Beyond The Breakthrough - From Approval To Adoption
A medical device can work beautifully and still go nowhere. In this episode of Strategic Intent, Krishna Eluri sits down with Mark Saxton, U...
Making The Case For Switch, With AESGP’s Christelle Anquez-Traxler
Products like ibuprofen and loratadine are now grabbed off a pharmacy shelf without a second thought, but both started out as prescription-o...
Advancing CNS Drug Development Through AI, New Approach Methodologies and Regulatory Innovation
Pharma Intelligence from Informa places biopharma and medical device professionals, and those who focus on these industries, at the forefron...
ZS On How AI is Reshaping The Patient's Approach to Care Delivery - a View From the US, China and Germany
A landmark three-country survey by the ZS consulting and technology firm , which shows the rapid trend towards patients' uptake of AI tools...
Drug Fix: MFN Finds Mid-Size Companies And More Vaccine Policy Moves
Pink Sheet Executive Editor Derrick Gingery, Senior Reporter Maaisha Osman, Senior Editor Sue Sutter and Editor-in-Chief Nielsen Hobbs consi...
【3分で解説 #世界のファーマ】第30回 米国、ジェネリック関税に国内外から懸念／BMSとAZ合併の噂 (Japanese-language podcast) Aug. 28, 2026
世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で発信する2つのオンラインメディアから、今注目の話題を日本語で短くまとめてお届けします。今回取り上げた記事はこちら. As US Threatens A Tari...
Videocast: Goodwin’s Sophie McGrath – A Legal View Of Healthtech And Biopharma Trends
A videocast for the In Vivo podcast section, with Goodwin's Sophie McGrath - talking about healthtech and pharma trends. Innovation, investm...
Drug Fix: What FDA Commissioner Nominee Heidi Overton Will Mean For The Agency
Pink Sheet Editor-in-Chief Nielsen Hobbs, executive editor Derrick Gingery, and senior reporter Maaisha Osman discuss new FDA commissioner n...
Bonus Episode: Inside Endocyclic’s Precision Peptide Strategy For Endometriosis Diagnosis And Treatment
One in ten women has endometriosis, yet treatment options remain largely unchanged for decades. Tanya Petrossian, CEO of EndoCyclic Therapeu...
Strategic Intent: The Rise Of Mid-Cap Dealmakers
Biopharma’s small-to-mid-cap players are stepping up as serious acquirers. David Wild and Scrip’s Jessica Merrill unpack how companies like...
Building The GLP-1 Companion Category, With Beverley Law And Martina Gripp
Everyone in consumer health is talking about GLP-1s. While this new generation of weight loss drugs is firmly on the prescription-only side,...